Kato S, Tsujimoto S-I, Matsubayashi J, Iwamoto S, Hiramatsu H, Okuno Y, Kamitori T, Ohki K, Deguchi T, Kiyokawa N, Kato M, Takita J, Tanaka S, Adachi S, Tomizawa D, Shiba N. Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1::RUNX1T1. Haematologica 2025; 110(1):251-256; https://doi.org/10.3324/haematol.2024.286243.